Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy.

"A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear propertie...

Full description

Saved in:
Bibliographic Details
Format: Electronic eBook
Language:English
Published: Vienna : International Atomic Energy Agency, 2015.
Series:IAEA radioisotopes and radiopharmaceuticals series ; no. 5,
Subjects:
Online Access: Full text (Wentworth users only)
Local Note:ProQuest Ebook Central